Floatz logo

Idursulfase Beta

GC1111

GC Biopharma Corpprotein_peptidePhase 3Dormant
BB
64/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the GC1111 cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

Idursulfase Beta is also rated in:

mucopolysaccharidosis type 2Dormant
BBB
Indicative ·
72 / 100
View asset →
mucopolysaccharidosis type 2Dormant
CCC
Indicative ·
53 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →